In process controls IPCs for blend uniformity, hardness, friability and thickness

In process controls IPCs for blend uniformity, hardness, friability and thickness In-Process Controls for Blend Uniformity, Hardness, Friability, and Thickness in Solid Oral Dosage Manufacturing In the manufacturing of solid oral dosage forms, particularly in granulation, tablet compression, and coating, compliance with regulatory standards is paramount. This tutorial discusses the in-process controls (IPCs) necessary to ensure blend uniformity, hardness, friability, and thickness in the production of GMP tablets. The objectives of this article are to provide a comprehensive understanding of IPCs in solid oral dosage manufacturing and offer step-by-step guidance for implementation and monitoring to meet FDA and international regulatory…

Continue Reading... In process controls IPCs for blend uniformity, hardness, friability and thickness

Raw material variability control for excipients in tablet and capsule processes

Raw material variability control for excipients in tablet and capsule processes Raw Material Variability Control for Excipients in Tablet and Capsule Processes Introduction to Solid Oral Dosage Manufacturing Solid oral dosage forms, particularly tablets and capsules, are a cornerstone of pharmaceutical manufacturing. The formulation and production of these products rely heavily on the selection and control of excipients—substances other than the active pharmaceutical ingredient (API) that are included in a drug product. Raw material variability can significantly impact the quality, efficacy, and safety of solid oral dosage forms. Thus, it is critical for pharmaceutical manufacturers to establish stringent controls to…

Continue Reading... Raw material variability control for excipients in tablet and capsule processes

Common FDA 483 observations in solid dose manufacturing and how to avoid them

Common FDA 483 Observations in Solid Dose Manufacturing and How to Avoid Them In the realm of solid oral dosage manufacturing, adherence to regulatory compliance is paramount. Regulatory bodies, particularly the US Food and Drug Administration (FDA), continuously monitor manufacturing processes to ensure drug safety and efficacy. This article delineates common FDA 483 observations related to solid dose manufacturing, elucidates why these issues occur, and offers step-by-step guidance on how to prevent them. Understanding FDA 483 and Its Implications The FDA Form 483 is issued to a firm when an investigator observes any condition that, in their judgment, may constitute…

Continue Reading... Common FDA 483 observations in solid dose manufacturing and how to avoid them

Tech transfer packages for solid oral products across global site networks

Tech Transfer Packages for Solid Oral Products Across Global Site Networks In the pharmaceutical industry, particularly in solid oral dosage manufacturing, the management of tech transfer packages plays a vital role in ensuring compliance with Good Manufacturing Practices (GMP) and maintaining high-quality standards. This comprehensive guide will delve into the step-by-step process of developing and implementing effective tech transfer packages for solid oral dosage forms such as tablets and capsules, and how these packages can facilitate successful transitions across global site networks. Understanding Tech Transfer in Pharmaceutical Manufacturing Tech transfer, in the context of pharmaceutical manufacturing, refers to the systematic…

Continue Reading... Tech transfer packages for solid oral products across global site networks

Using PAT tools for real time monitoring of moisture, density and coating weight

Using PAT Tools for Real-Time Monitoring of Moisture, Density, and Coating Weight in Solid Oral Dosage Manufacturing In the rapidly evolving pharmaceutical industry, the emphasis on quality and compliance is paramount. Particularly in the production of solid oral dosage manufacturing, the implementation of Process Analytical Technology (PAT) tools has become increasingly prevalent. PAT tools facilitate real-time monitoring and control of critical parameters, ultimately enhancing product quality and compliance with *Good Manufacturing Practices (GMP)*. This article presents a comprehensive guide on using PAT tools for monitoring moisture, density, and coating weight throughout the granulation, compression, and coating processes. Understanding the Regulatory…

Continue Reading... Using PAT tools for real time monitoring of moisture, density and coating weight

Deviation trending in granulation, compression and coating lines and CAPA

Deviation trending in granulation, compression and coating lines and CAPA Deviation trending in granulation, compression and coating lines and CAPA Introduction to Solid Oral Dosage Manufacturing Solid oral dosage forms, including tablets and capsules, represent a significant portion of pharmaceuticals produced worldwide. The manufacturing processes for these dosage forms, such as the granulation process, tablet compression, and tablet coating, are critical to ensuring the safety, efficacy, and quality of the final product. The adherence to Good Manufacturing Practices (GMP) is essential throughout these processes to minimize risks and ensure product integrity. This tutorial outlines the importance of identifying and trending…

Continue Reading... Deviation trending in granulation, compression and coating lines and CAPA

Operational excellence projects focused on OEE in solid oral dosage lines

Operational Excellence Projects Focused on OEE in Solid Oral Dosage Lines In the pharmaceutical manufacturing sector, operational efficiency is paramount. This tutorial provides a comprehensive guide to improving Overall Equipment Effectiveness (OEE) in solid oral dosage manufacturing, focusing on the key processes of granulation, tablet compression, and tablet coating. It also addresses compliance with FDA regulations, essential for ensuring that pharmaceutical products meet required quality standards. Understanding Overall Equipment Effectiveness (OEE) Overall Equipment Effectiveness (OEE) is a crucial metric in pharmaceutical manufacturing, particularly in the production of solid oral dosage forms, such as tablets and capsules. OEE evaluates how effectively…

Continue Reading... Operational excellence projects focused on OEE in solid oral dosage lines

Process validation strategies for high speed compression and film coating

Process Validation Strategies for High Speed Compression and Film Coating In the highly regulated realm of solid oral dosage manufacturing, process validation is pivotal to ensure that manufactured products meet quality standards as defined by the US FDA and other international regulatory bodies. This tutorial outlines a step-by-step guide to process validation strategies specific to high-speed compression and film coating processes. The emphasis will be on regulatory compliance, implementing Quality by Design (QbD), and utilizing process analytical technology (PAT) tools. Understanding the Importance of Process Validation in Solid Oral Dosage Manufacturing Process validation in solid oral dosage manufacturing is essential…

Continue Reading... Process validation strategies for high speed compression and film coating

Batch record design for solid dose manufacturing aligned with data integrity

Batch Record Design for Solid Dose Manufacturing Aligned with Data Integrity In the realm of pharmaceutical manufacturing, particularly in solid oral dosage manufacturing, adherence to stringent regulatory standards like those of the FDA is critical. The design of batch records is a crucial element in ensuring compliance with Good Manufacturing Practices (GMP) and data integrity. This tutorial provides a comprehensive, step-by-step guide to developing batch records for solid dose manufacturing, focusing on key processes such as granulation, tablet compression, and tablet coating. Understanding the Regulatory Framework for Batch Records The FDA’s Title 21 of the Code of Federal Regulations outlines…

Continue Reading... Batch record design for solid dose manufacturing aligned with data integrity

Visual inspection, defect classification and AQL sampling for coated tablets

Visual Inspection, Defect Classification and AQL Sampling for Coated Tablets Introduction to Visual Inspection in Solid Oral Dosage Manufacturing Visual inspection is an essential quality control process in the manufacturing of solid oral dosage forms, such as coated tablets. It plays a critical role in ensuring that products meet the regulatory and quality standards set forth by the FDA and equivalent regulatory agencies in the UK and EU. Effective visual inspection not only safeguards patient safety but also minimizes the risk of product recalls and regulatory scrutiny. This article will provide a comprehensive tutorial on the visual inspection methods, defect…

Continue Reading... Visual inspection, defect classification and AQL sampling for coated tablets